We Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt With Ease - Simply Wall St
2 weeks ago • Google News
Torrent Pharmaceuticals Limited (TORNTPHARM)
NSEINR 3223.1-0.24%
Price Chart
Key Statistics
Market Cap
INR 1.09T
P/E Ratio
58.47
Revenue (TTM)
INR 113.02B
Volume
477.31K
52W High
INR 3562.90
52W Low
INR 2480.68
Dividend Yield
0.99%
Beta
0.32
Technicals
50-Day MA
3128.704
200-Day MA
3226.958
52 Week High
3562.9003
52 Week Low
2480.685
About TORNTPHARM
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationa.
Employees
15718
Headquarters
Ahmedabad, India
CEO
Mr. Samir Uttamlal Mehta B.Com., MBA
Latest News
TORNTPHARM Outlook for the Week (March 17, 2025 – March 21, 2025) - EquityPandit
2 weeks ago • Google News
Torrent Pharmaceuticals Q2 Results: Profit Up 17% But Misses Estimates - NDTV Profit
2024-10-25 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg